Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes

British Journal of Dermatology

Volumn 134, Issue 4, 1996, Pages 643-648

  Sirsjo A ^a   Karlsson, M ^a   Gidlof A ^a   Rollman, O ^b   Torma H ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; KERATINOCYTE; MALE; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PSORIASIS; SKIN INFLAMMATION;

EID: 0029879905     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb06963.x     Document Type: Article

References (43)

1. Ohta Y, Katayama I, Funato T et al. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions. Arch Dermatol Res 1991; 283: 351-6.
2. Schmid P, Cox D, McMaster C, et al. In situ hybridization analysis of cytokine, proto-oncogene and tumour suppressor gene expression in psoriasis. Arch Dermatol Res 1993; 285: 334-40.
3. Löntz W, Sirsjö A, Liu W, et al. Increased mRNA expression of manganese-superoxide dismutase in psoriatic lesions and in cultured keratinocytes treated with inlerteukin-1β and tumor necrosis factor-α. Free Radical Biol Med 1995; 216: 358-62.
4. Braverman I. Electron microscopic studies of the microcirculation in psoriasis. J Invest Dermatol 1972; 59: 91-8.
5. 133xenon clearance. J Invest Dermatol 1970; 54: 381-5.
6. Pinkus H, Mehregan AH. The primary histologic lesion of seborrheic dermatitis and psoriasis. J Invest Dermatol 1966; 46: 109-16.
7. Telner P, Fekete Z. The capillary response in psoriatic skin. J Invest Dermatol 1961; 36: 225-30.
8. Goodfield M, Hull SM, Holland D et al. Investigations of the 'active' edge of plaque psoriasis: vascular proliferation precedes changes in epidermal keratin. Br J Dermatol 1994; 131: 808-13.
9. Knowles RG, Moncada S. Nitric oxide as a signal in blood vessels. Trends Biochem Sci 1992; 17: 399-402.
10. Knowles R, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298: 249-58.
11. Mellion BT, Ignarro LJ, Ohlstein RH, et al. Evidence for the inhibitory role of guanosine 3′.5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 1981; 57: 946-55.
12. Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 1991; 41: 485-90.
13. Wood HR, Berger HJ, Sherman PA et al. Hepatocytes and macrophages express an identical cytokine inducible nitric oxide synthase gene. Biochem Biophys Res Commun 1993; 191: 767-74.
14. Nunokawa Y, Ishida N, Tanaka S. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle. Biochem Biophys Res Commun 1993; 191: 89-94.
15. Sirsjö A, Söderquist P, Sundquist T et al. Different induction mechanisms of mRNA for inducible nitric oxide synthase in rat smooth muscle cells in culture and in aortic strips. FEBS Lett 1994; 338: 191-6.
16. Xie QW, Cho HJ, Calaycay J et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992; 256: 225-8.
17. Xie Q-W, Nathan C. The high-output nitric oxide pathway: role and regulation. J Leukocyte Biol 1994; 56: 82.
18. Nathan C, Hibbs JJ. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3: 65-70.
19. Hibbs JBJ, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987; 235:473-6.
20. Lepoivre M, Chenais B, Yapo A et al. Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J Biol Chem 1990; 265: 14143-9.
21. Rollman O, Wood EJ, Olsson MJ et al. Biosynthesis of 3,4-didehydroretinol from retinol by human skin keratinocytes in culture. Biochem J 1995; 293: 675-82.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
23. 3, and thyroid hormone (c-erb-A) nuclear receptors in human skin using reverse transcription and polymerase chain reaction. Acta Derm Venereol (Stockh) 1993; 73: 102-7.
24. Nakane M, Schmidt HH, Pollock JS et al. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 1993; 316: 175-80.
25. Janssens SP, Shimoushi A, Quertermous T et al. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992; 267: 14519-22.
26. Geller DA, Lowestein CJ, Shapiro RA et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993; 90: 3491-5.
27. Hallewell RA, Masiarz FR, Najarian RC et al. Human Cu/Zn superoxide dismutase cDNA: isolation of clones synthesising high levels of active or inactive enzyme from an expression library. Nucleic Acids Res 1985; 13: 2017-34.
28. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; ii: 997-1000.
29. Springall D, Riveros-Moreno V, Buttery L et al. Immunological detection of nitric oxide synthases in human tissues using heterologous antibodies suggesting different isoforms. Histochemistry 1992; 98: 259-66.
30. Moncada S, Palmer R, Higgs E. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-42.
31. Rees DD, Palmer RMJ, Moncada S. The role of endothelium derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989; 86: 3375-8.
32. Kolb-Bachofen V, Fehsel K, Michel G et al. Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of psoriasis vulgaris. Lancet 1994; 344: 139.
33. Cooper K, Hammerberg C, Baadsgaard O et al. IL-1 activity is reduced in psoriatic skin: decreased IL-1 alpha and increased nonfunctional IL-1 beta. J Immunol 1990; 144: 4593-603.
34. Rowe A, Farrell A, Kazmi SH et al. Expression of inducible nitric oxide synthase in dermal microvasculature in psoriasis. Lancet 1994; 344: 1371.
35. Warren JB. Nitric oxide and human skin blood flow responses to acetylcholine and ultraviolet light. FASEB J 1994; 8: 247-51.
36. Salvemini D, Misko T, Masferrer J et al. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993; 90: 7240-4.
37. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-7.
38. Nakaki T, Nakayama M, Kato R. Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol 1990; 189: 347-53.
39. Ziche M, Morbidelli L, Masini E et al. Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. Biochem Biophys Res Commun 1993; 192: 1198-203.
40. Geng Y-J, Hansson GK, Holme E. Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circulation Res 1992; 71: 1268-76.
41. Nunokawa Y, Tanaka S. Interferon-γ inhibits proliferation of rat vascular smooth muscle cells by nitric oxide generation. Biochem Biophys Res Commun 1992; 188: 409-15.
42. Heck D, Laskin D, Gardner C et al. Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. J Biol Chem 1992; 267: 21277-80.
43. Arock M, Becherel P, Le Goff L et al. Anti-proliferative effects of CD23 ligation on normal human keratinocytes: Involvement of TNF-α and nitric oxide. J Invest Dermatol 1994; 103: 422.